How to manage diabetes in advanced terminal illnesses
Smyth, T.; Smyth, D.
Nursing Times 101(17): 30-32
2005
ISSN/ISBN: 0954-7762 PMID: 15881905 Document Number: 590043
Diabetes mellitus is increasing in incidence and is therefore being encountered more frequently during palliative care. Diabetes management in the early stages of terminal disease is normally the same as conventional care. However, in the later stages of terminal illness there are a number of problems that may arise due to diabetes treatment, including hypoglycaemia and hyperglycaemia, which may impair the patient's quality of life. This article will address some of these problems and their management.
Document emailed within 1 workday
Related Documents
Bou Khalil, M.K. 2008: Pain management in children with terminal illnesses Le Journal Medical Libanais. Lebanese Medical Journal 56(2): 93-99Kuhlmey, J. 1992: The panorama of illnesses in advanced age. on the possibilities and reality of therapy Zeitschrift für Arztliche Fortbildung 86(11): 565-570
Kang'ethe, S.M. 2009: Challenges impacting on the quality of care to persons living with HIV/AIDS and other terminal illnesses with reference to Kanye community home-based care programme Sahara J: Journal of Social Aspects of Hiv/Aids Research Alliance 6(1): 24-32
Kang'ethe, S.M. 2009: Challenges impacting on the quality of care to persons living with HIV/AIDS and other terminal illnesses with reference to Kanye community home-based care programme Sahara J: Journal of Social Aspects of Hiv/Aids Research Alliance 6(1): 24-32
Blank, I. 2001: Diabetes mellitus: the greatest number of illnesses since temptation became prevalent Pflege Zeitschrift 54(9): 609-614
Schroeder, S. 2018: Quality Focus: Manage and Prevent Diabetes by Combining Education and Treatment South Dakota medicine: the journal of the South Dakota State Medical Association 71(11): 523
Madrid, F.; Romero, C.; Barrio, J.L. 1997: HIV infection at an advanced or terminal stage Anales de Medicina Interna 14(11): 595-6; Author Reply 596-7
Talwar, G.P. 2013: A unique vaccine for control of fertility and therapy of advanced-stage terminal cancers ectopically expressing human chorionic gonadotropin Annals of the new York Academy of Sciences 1283: 50-56
Lee, E.; Tatara, N.; Arsand, E.; Hartvigsen, G. 2011: Review of mobile terminal-based tools for diabetes diet management Studies in health technology and informatics 169: 23-27
Pérez García, R.; Rodríguez Benítez, P.; Dall'Anesse, C.; Gómez Campderá, F.; Valderrábano, F. 2001: Pre-occupying increase in diabetes as cause for terminal kidney failure. Evaluation of treatment strategies Anales de Medicina Interna 18(4): 175-180
Rzaev, N.M.; Mirsalimov, F.M.; Zakirdzhaev, D.D.; Seidov, V.D.; Agaev, R.A. 1982: Reconstructive surgery on the terminal segment of the abdominal aorta and its principal branches in diabetes mellitus Khirurgiia 9: 13-16
Nacchiero, M.Cosimo.; Verderosa, G.; Muscatiello, N.; Della Valle, N.; Diterlizzi, F.; Tricarico, F.; Di Gioia, G.; Melino, R.; Panella, C.; Ierardi, E. 2010: Advanced adenocarcinoma of terminal ileum: an unusual neoplasm revealed by an unusual diagnostic tool Acta Bio-Medica: Atenei Parmensis 81(3): 230-232
Chiarelli, F.; Mansour, M.; Verrotti, A. 2000: Advanced glycation end-products in diabetes mellitus, with particular reference to angiopathy Diabetes Nutrition and Metabolism 13(4): 192-199
González, M.; Paquién, C.; Asenjo, S.; Gleisner, A.; Kirsten, L.; Bustamante, M. 2001: Autoantibodies against advanced glycation products in patients with type 1 diabetes mellitus Revista Medica de Chile 129(2): 141-148
Renner, R. 1999: Advanced education by the Diabetes Society. Diabetic cheiropathy and related diseases MMW Fortschritte der Medizin 141(23): 47-49
Francini, G.; Nami, R.; Gonnelli, S.; Groppa, A.; Montagnani, M.; Gennari, C. 1982: Radioimmunoassay for the N-terminal, C-terminal and middle region of human parathyroid hormone in bone diseases Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 18(4): 486-492
Capodici, C.; Weiss, J. 1996: Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function Journal of Immunology 156(12): 4789-4796
Nakamura, N.; Yamazaki, K.; Satoh, A.; Urakaze, M.; Kobayashi, M.; Yamabe, H.; Osawa, H.; Shirato, K.-I.; Sugawara, T.; Nakamura, M.; Tamura, M.; Okumura, K. 2003: Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes In Vivo 17(2): 177-180
Triolo, G.; Giardina, E.; Casiglia, D.; Scarantino, G.; Bompiani, G.D. 1991: Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor Clinical and Experimental Immunology 84(1): 53-58
Sinawat, S.; Thanapaisal, S.; Sinawat, S. 2014: Advanced exudative retinopathy with neovascular glaucoma as the clinical presentation of diabetes mellitus and severe combined hyperlipidemia: a case report Journal of the Medical Association of Thailand 97 Suppl. 10: S110-S114